Antioxidants in Patients Treated for Cancer
Ready to Claim Your Credits?
You have attempts to pass this post-test. Take your time and review carefully before submitting.
Good luck!
Overview
For our patients undergoing cancer treatment, what role do antioxidant substances play? Further, should we encourage or actively discourage these patients from taking them? Dr. Brian Lawenda, assistant professor of radiation oncology at the Indiana University School of Medicine, discusses the rationale for and against the use of antioxidants in patients receiving both chemotherapy and radiation therapy with your host, Dr. Lee Freedman.
Overview
For our patients undergoing cancer treatment, what role do antioxidant substances play? Further, should we encourage or actively discourage these patients from taking them? Dr. Brian Lawenda, assistant professor of radiation oncology at the Indiana University School of Medicine, discusses the rationale for and against the use of antioxidants in patients receiving both chemotherapy and radiation therapy with your host, Dr. Lee Freedman.
Title
Share on ReachMD
CloseProgram Chapters
Segment Chapters
Playlist:
Recommended
Updates From the 7th World Symposium Task Force
Episode 2 Part B: Effectively Transferring Over the CKD Patient at the Right Time
Distinguishing Between Anti-PD-1 Agents in ESCC Combination Therapies
The Importance of PD-L1 Testing: Shaping the Future of Treatment in ESCC
Respiratory Dysfunction in Neuromuscular Disorders: Evaluating Symptoms
Clinical Strategies for Assessing Sleep Disturbances in Postpartum Patients
mIDH Gliomas Explained: Characteristics and Management Strategies
From Diagnosis to Treatment: Challenges in Glioblastoma Care
We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?